Clinical trial NCT03217864: Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg
Official title: Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg: Observational, Prospective, Monocentric, Non-interventional Study. Advantages, Disadvantages, Limitations
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cancer
Keywords: Cancer
palliative care
hospitalization at home
home health care provider
Lead sponsor: University Hospital, Strasbourg, France
Sponsor class: OTHER
First posted: 2017-07-14
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient over 18 years old for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of of the University Hospital of Strasbourg.

Brief summary: Hospitalization at home is booming. It is designed to meet the demands of patients and their families to continue care at home. It partially solves the problem of the lack of places in the "long-term care" structures and allows to respond to a desire of the health policy to reduce the lengths of stay in the hospital. Hospitalization at home is also an alternative in the management of chronic patients. Nevertheless, at the moment a certain number of requests for hospitalization at home remain unsuccessful or their implementation is complicated. In addition, the number of home health care provider has increased significantly in recent years. According to the federation of home health care provider, the number of beneficiaries increased by 1.7% in 4 years. The home health care provider would support 1,200,000 patients per year.

The objective of the study is to analyze the factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider during a return home project constructed with the patient and his / her relatives from the services of Oncology, oncology, hematology of the University Hospital of Strasbourg.


Eligibility criteria: Inclusion Criteria:

* Patient over 18 years old
* Patient for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of the University Hospital of Strasbourg.

Exclusion Criteria:

* Refusal to participate in the study

Primary outcomes:
measure: Analysis of factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider
timeFrame: 15 days after patient discharge from hospital
Secondary outcomes:
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Service Soins Palliatifs
Study officials:
affiliation: University Hospital, Strasbourg, France
name: Laurent CALVEL, MD, PhD
role: STUDY_DIRECTOR
affiliation: University Hospital, Strasbourg, France
name: Marie DEMEUSE, MD
role: PRINCIPAL_INVESTIGATOR
References: